Stem Cells, FDA, and the Edge of Science: Three Expert Viewpoints - Forbes
www.forbes.com
Last week I wrote about a pending lawsuit by the FDA against Regenerative Sciences, a medical company that developed a stem cell treatment for orthopedic injuries. While adult stem cell therapies have been fraught with concerns about safety and efficacy, this case is particularly important not only...